Stock listing
Biocardia, Inc.
Selected listing: BCDA · NASDAQ · USD · US
Biocardia, Inc. (NASDAQ:BCDA), Health Technology. Latest release Oct 7, 2026: BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society…
- Ticker
- NASDAQ:BCDA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Biocardia, Inc.
Biocardia, Inc. is a public company traded under the ticker BCDA in the American market. Biocardia focuses on developing innovative therapies for cardiovascular diseases.
Latest news from Biocardia, Inc.
BioCardia Presents CardiAMP HF II Trial Design at Heart Failure Society of America Annual Scientific Meeting
October 6, 2026
BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter
October 1, 2026
BioCardia Confirms Timing and Provides Update on FDA Helix Pre-Submission and PMDA CardiAMP HF Shonin Submission
September 23, 2026
BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference
September 10, 2026
BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval
August 24, 2026
Events
Research Biocardia, Inc.
Alternate listings
BCDA:BOATS
US · USD
Alternate listing for Biocardia, Inc.; the primary context on this page is BCDA:NASDAQ.
6JU0:FWB
DE · EUR
Alternate listing for Biocardia, Inc.; the primary context on this page is BCDA:NASDAQ.
6JU0:GETTEX
DE · EUR
Alternate listing for Biocardia, Inc.; the primary context on this page is BCDA:NASDAQ.
A40D1S:LS
DE · EUR
Alternate listing for Biocardia, Inc.; the primary context on this page is BCDA:NASDAQ.